Acc 200, 20 capsules, Sandoz
Active substance:
Acetylcysteine.
Indications:
Respiratory disorders. In pneumology: Acute and chronic forms of respiratory diseases, especially in acute and chronic bronchitis, bronchiectasis (enlargement of the bronchial branches), asthmatic bronchitis, bronchiolitis (inflammation of the small bronchial tract), cystic fibrosis (genetic metabolic disorder). In ENT: Laryngitis, acute and chronic sinusitis, otitis media with suppuration.
Composition:
One capsule contains 200 mg acetylcysteine, mannitol, stearic acid, dye E 171.
Method of administration:
Unless otherwise indicated, the following 200 mg acetylcysteine administration is recommended: Adults and young persons over 14 years of age: three times a capsule of ACC 200 three times a day. Children 6-14 years of age: twice a day ACC 200. Children between 2-5 years: once a day a capsule of ACC 200, especially in the evening. In patients with cystic fibrosis, a predisposition to bronchitis and weighing more than 30 kg, the dose may be increased to 800 mg. Method and duration of treatment: The capsules are administered as such with liquids after meals. The duration of treatment will be determined individually. In chronic bronchitis and cystic fibrosis, a long-term treatment will be performed to achieve a prophylaxis of infections. Caution The secretolytic effect of acetylcysteine is potentiated with liquids. The medicine should not be used after the expiry date which is stated on the pack.
Contraindications:
Contraindications are conditions or situations in which certain drugs can not be used or are used only after a complex medical analysis, because in this case, the beneficial effect is not in a favorable relationship with their negative effect.
Under these conditions, the doctor must be correctly and fully informed about previous illnesses, diseases associated with concomitant treatment and the conditions that individualize the case. Sometimes contraindications may occur or may be known after starting treatment. And in this case the doctor must be informed. ACC 200 should not be used in children under 2 years of age due to its high acetylcysteine content. ACC 200 should not be used in cases of hypersensitivity to acetylcysteine.
Pregnancy and lactation:
As there are no experiences of use during pregnancy and lactation, it is recommended not to use it during these periods.
Side effects:
Medicines can have, in addition to the main desired actions and side effects, so-called side effects. Adverse effects that are related to the temporary use of acetylcysteine, but which should not occur in every patient, are listed below: Inflammation of the oral mucosa (stomatitis), headache and ringing in the ears (tinnitus) are rare. In isolated reports, allergic reactions such as acetylcysteine are reported, e.g. itching, hives, rash, suffocation (bronchospasm), tachycardia and low blood pressure. Isolated cases of bronchial spasm refer mainly to patients with an overactive bronchial system in asthma, those called "hyper-responder" (hypersensitivity to different agents). In addition, cases of bleeding have been reported in connection with the administration of acetylcysteine, especially in hypersensitivity reactions. A decrease in platelet aggregation has also been reported in the presence of acetylcysteine, although this cannot be clinically demonstrated.
Interactions with other drugs:
The action of some drugs can be influenced by the concomitant use of others. Therefore, ask your doctor if you are constantly taking or have recently taken any other medicines, or if you want to use them at the same time as this medicine. Your doctor may tell you if side effects may occur under these conditions or if certain measures need to be taken, such as whether another dose needs to be taken with this medicine. The following interactions between the preparation presented and others must be taken into account: When concomitant use of acetylcysteine with antitussives, secretion may be stopped due to a reduced cough reflex, so that the indication for this combination is particularly prudent. The administration of tetracycline hydrochloride (not only doxycycline) should be done separately or at least two hours after administration. The vasodilating and influencing effect on platelet aggregation when co-administered with nitroglycerin has also been reported but not clinically elucidated.
Presentation:
20 capsules